Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase III Trial of Surgery Plus Neoadjuvant TS-1 and Cisplatin Compared With Surgery Alone for Type 4 and Large Type 3 Gastric Cancer: Japan Clinical Oncology Group Study (JCOG 0501)

NCT00252161 is registered in ClinicalTrials.gov with Haruhiko Fukuda as lead sponsor.

NCT NCT00252161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00252161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase III Trial of Surgery Plus Neoadjuvant TS-1 and Cisplatin Compared With Surgery Alone for Type 4 and Large Type 3 Gastric Cancer: Japan Clinical Oncology Group Study (JCOG 0501)
Lead sponsor
Haruhiko Fukuda
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2005
Completion date
April 30, 2015
Enrollment
316 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

gastric neoplasm